Sequential Treatment of Postmenopausal Women With Primary Osteoporosis (FP-001-IM)

Mise à jour : Il y a 4 ans
Référence : NCT00365456

Femme Homme

  • | Pays :
  • Denmark
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The objective is to show superior efficacy of PTH (1-84) over risedronate in treating osteoporotic women for 12 months after having previously been treated with PTH (1-84) for 12 months followed by 12 months treatment with risedronate.


Critère d'inclusion

  • Osteoporosis

Liens